The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children
Authors:
Top Cited Papers
Open Access
- 26 May 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0156465
Abstract
To analyze the clinical characteristics of refracory Mycoplasma pneumoniae pneumonia (RMPP), and explore the related factors predicting RMPP. Retrospective analysis was performed on 634 children with Mycoplasma pneumoniae pneumonia (MPP) hospitalized in our hospital between January 1, 2011 and December 31, 2014. The clinical features, laboratory data, radiological findings between the RMPP group and the general Mycoplasma pneumoniae pneumonia (GMPP) group were compared and the predictive values of related factors were analyzed. The median age of the RMPP patients (n = 145) was much older than that of the GMPP patients (n = 489) (P<0.01). We also found more severe presentations, higher incidence of extra-pulmonary complications and more serious radiological findings in RMPP group, which needed oxygen more often, longer antibiotics administration and intensive care (P<0.05). Meanwhile, the levels of C-reactive protein (CRP), lactic dehydrogenase (LDH), immunoglobulin A (IgM), interleukin (IL)-6, IL-10, interferon gamma (IFN-γ) and the percentage of neutrophils, CD8+ in RMPP group were significantly higher than those in GMPP group (P<0.05); while the levels of prealbumin (PAB) were lower than that in GMPP group (P<0.01). In ROC curve analysis, the percentage of neutrophil, CRP, LDH, PAB, IL-6, IL-10 and IFN-γ were useful for differentiating patients with RMPP from those with GMPP. Multiple logistic regression analysis showed that the CRP≥16.5mg/L, LDH ≥417IU/L and IL-6 ≥14.75pg/ml were significant predictors regarding to RMPP. CRP≥16.5mg/L, LDH ≥417IU/L and IL-6 ≥14.75pg/ml might be the significant predictors of RMPP in children, which can aid in early recognition of RMPP.Keywords
Funding Information
- National Natural Science Foundation of China (81401301)
- National Natural Science Foundation of China (81501374)
- National Natural Science Foundation of China (81200022)
This publication has 35 references indexed in Scilit:
- Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in childrenInternational Journal of Infectious Diseases, 2014
- Management of refractory Mycoplasma pneumoniae pneumonia: Utility of measuring serum lactate dehydrogenase levelJournal of Infection and Chemotherapy, 2014
- Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumoniaJournal of Infection and Chemotherapy, 2011
- High Prevalence of Macrolide Resistance inMycoplasma pneumoniaeIsolates from Adult and Adolescent Patients with Respiratory Tract Infection in ChinaClinical Infectious Diseases, 2010
- Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia: case report and literature reviewThe Brazilian Journal of Infectious Diseases, 2009
- Epidemiology and clinical features of Mycoplasma pneumoniae infection in childrenRespiratory Medicine, 2008
- Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in childrenJournal of Infection, 2008
- Bronchiolitis Obliterans in the 1990s in Korea and the United StatesChest, 2001
- Neurological Symptoms in Patients Whose Cerebrospinal Fluid Is Culture- and/or Polymerase Chain Reaction-Positive for Mycoplasma pneumoniaeClinical Infectious Diseases, 2001
- Severe Acute Lung Injury Caused byMycoplasma pneumoniae: Potential Role for Steroid Pulses in TreatmentClinical Infectious Diseases, 2000